SCHEMBL12626015

SCHEMBL12626015

CB(O)N1CCC2(CC1)OCCN2S(=O)(=O)c1ccc(C(C)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ HCRTR1 O43613 2/20 0.48
▸ HCRTR2 O43614 2/20 0.48
▸ NPC1 O15118 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12621830 0.85 ALDH1A1 (0.59) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623948 0.85 LMNA (0.57) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12621896 0.83 HCRTR1 (0.56) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623975 0.82 ALDH1A1 (0.51) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623932 0.82 ALDH1A1 (0.56) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623977 0.81 HCRTR1 (0.51) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12626027 0.81 ALDH1A1 (0.49) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12673411 0.80 ALDH1A1 (0.48) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623974 0.80 ALDH1A1 (0.48) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1
SCHEMBL12623972 0.79 ALDH1A1 (0.47) ALDH1A1L3MBTL1HCRTR1HCRTR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251374-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC BURNS BARBIER LINDSAY (US) 2016-09-01 — — US disclosed
US-9340558-B2 Filamin a binding anti-inflammatory and analgesic PAIN THERAPEUTICS INC. (US) 2016-05-17 — — US disclosed
US-8653068-B2 Filamin A binding anti-inflammatory and analgesic PAIN THERAPEUTICS, INC. (US) 2014-02-18 — — US disclosed
US-8580808-B2 Filamin A-binding anti-inflammatory analgesic Pain Therapeutic, Inc. (US) 2013-11-12 — — US disclosed
US-8580809-B2 Filamin A-binding anti-inflammatory analgesic PAIN THERAPEUTICS, INC. (US) 2013-11-12 — — US disclosed
US-20110105484-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed
US-20110105487-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed
US-20110105481-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed
US-20110105547-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160251374-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC FLNA, FLNB, OPRK1 ALDH1A1 2575/4885L3MBTL1 3291/4885HCRTR1 3880/4885
US-20110105487-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC FLNA, FLNB, FPR1 ALDH1A1 3041/4885L3MBTL1 4055/4885HCRTR1 4172/4885
US-20110105484-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC FLNA, FLNB, OPRK1 ALDH1A1 2702/4885L3MBTL1 3970/4885HCRTR1 3537/4885
US-20110105547-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC FLNA, FLNB, OPRK1 ALDH1A1 2702/4885L3MBTL1 3970/4885HCRTR1 3537/4885
US-20110105481-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC FLNA, FLNB, OPRK1 ALDH1A1 2575/4885L3MBTL1 3291/4885HCRTR1 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback